Background: Small bowel obstruction (SBO) is a well-known major postoperative
| INTRODUC TI ON
Among several complications occurring after abdominal surgery, it is well known that small bowel obstruction (SBO) is one of the most important and common. 1 In order to reduce the incidence of postoperative SBO (PSBO), surgeons have explored a number of options for minimizing intra-abdominal adhesion. These have included active use of laparoscopic surgery instead of open surgery 2 and the use of adhesion barrier film to prevent adhesion between the small bowel and the abdominal wall. 3 However, PSBO still remains a serious problem. 4 There are two basic types of intervention for PSBO: conventional and surgical. Conventional intervention should be undertaken as a first choice before surgical intervention because of its low degree of invasiveness. 5 Among such interventions, giving water-soluble contrast medium (WSCM) through a nasogastric tube (NG tube) should be carried out after immediate decompression, because this type of medium is considered to be useful for not only diagnosis 6 but also for treatment of SBO through its osmic effect. 7 However, although several reports have demonstrated the usefulness of this treatment for PSBO, 8 its effects are still controversial. 8, 9 In the present study, therefore, we carried out a meta-analysis to investigate whether giving Gastrografin (Bayer Healthcare, Loos, France), a WSCM, can reduce the need for surgery in PSBO patients without long-tube insertion.
| MATERIAL S AND ME THODS

| Search strategy
A systematic literature search was conducted using the Cochrane Library, MEDLINE, PubMed and the Web of Science covering papers published up to February 2017. The search was restricted to Englishlanguage articles. Search terms used were "small bowel obstruction"
and "Gastrografin". Of those identified as potentially relevant, complete articles were retrieved and evaluated for inclusion. References from all of the relevant articles were hand-searched for additional studies.
The meta-analysis and search strategy complied with the guidelines of Preferred Reporting Items for Systematic reviews and MetaAnalyses (PRISMA) 2010. 10 Therefore, the PICO criteria for this 
| Inclusion and exclusion criteria
| Study selection and data extraction
Full-text reviews were carried out independently by two of the authors (M.I. and N.S.) on the basis of the inclusion and exclusion criteria and PICO. Any disagreements were resolved by discussion and consensus. The same two authors also independently extracted the following information from each eligible article: first author's name, year of publication, nation in which the study was carried out, study design, number of patients with PSBO undergoing surgery, and sample size. If the necessary data could not be extracted from the publication, we contacted the original authors directly whenever possible.
| Data synthesis and statistical analysis
Review Manager (ver. Statistical heterogeneity was complemented with the I 2 statistic, which qualified the proportion of total variation across studies that was due to heterogeneity rather than to chance. Presence of publication bias was assessed by funnel plot. Forest plots were demonstrated in order by weight of each study. P value < 0.05 was considered to indicate statistical significance.
Ethical approval was not required because this was a metaanalysis of previously published literature.
| RE SULTS
| Study identification and eligibility
An electronic search yielded 234 articles, of which 105 were regarded as duplicate articles based on a title search. Among the remaining articles, 116 were excluded by title/abstract review on the basis of their selection criteria and PICO. The remaining 17 articles were screened by full-text review, after which 12 studies including a total of 1153 patients with PSBO were regarded as suitable for inclusion in the data synthesis. 9, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] The selection process for exclusion is shown in Figure 1 .
| Characteristics of included studies
All of the 12 studies were RCT. Among them, two were designed as multicenter RCT. 10, 18 Basic characteristics of the 12 included studies are shown in Table 1 .
| Association between giving Gastrografin and surgery for PSBO
Data on surgery for PSBO were available for all 12 RCT.
With regard to the dose of Gastrografin given, 10 studies recommended 100 mL. Among them, one study recommended 60 mL
Gastrografin for pediatric patients 21 and one study added 100 mL barium to 100 mL Gastrografin. 13 One study recommended 150 mL Gastrografin 17 and one study recommended 60 mL Gastrografin.
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No Gastrografin-related complications (eg, fluid or electrolyte disturbance, aspiration pneumonia, or exacerbation of obstructive episodes) 11 were reported. In fact, previous studies have shown that complications, including allergic reactions, resulting from the use of Gastrografin are rare. 22 In all 12 RCT, Gastrografin was given through a NG tube. In one study, the timing of dosage was defined as after 2 hours of NG-tube aspiration; 9 in the other 11 studies, the timing of Gastrografin dosage by a NG tube was not clearly stated. Not all patients received long-tube insertion.
Indications for surgery after receiving Gastrografin are shown in Table 1 . Patients who were and who were not given Gastrografin were considered to require surgery if features of strangulation or peritonitis appeared during the in-hospital course.
Among 580 patients who received Gastrografin, 100 (17.2%) underwent surgery, whereas among 573 patients who did not receive 
| D ISCUSS I ON
A systematic literature search has shown that two types of WSCM Therefore, we extracted Urografin from this study.
Theoretically, giving Gastrografin is recommended for conservative treatment of patients with PSBO before surgery because it has a very high osmolality and acts by drawing water into the lumen of the small bowel, thus reducing small bowel wall edema and assisting and PSBO studies. Similarly, the other 9 of the latter two studies, which was the latest of the total of four meta-analyses, included the largest number of patients with PSBO among the 10 included studies.
Moreover, in comparison with the four previous metaanalyses, 9,24-26 our present findings clearly confirmed the usefulness of Gastrografin for reducing the need for surgery, especially as it was based on the largest number of both patients and RCT. Our analysis did not include any study that had used Urografin as WSCM for treatment of patients with PSBO. In fact, among the 12 RCT, three clearly indicated the usefulness of Gastrografin for treatment of PSBO. 16, 17, 19 Furthermore, none of the analyzed RCT clearly contraindicated Gastrografin for treatment of such patients. Therefore, our present analysis has been able to provide new evidence for the utility of Gastrografin based on the four previous meta-analyses. Unlike the situation in most western countries, long-tube insertion is generally carried out in Japan to treat patients with PSBO. 27 Because only one small prospective RT of short versus long-tube insertion for adhesive SBO showed no significant therapeutic difference between the two as a conventional therapy, 28 this may explain why short-tube insertion has commonly been recommended in western countries. In fact, in all of the RCT we analyzed, Gastrografin was given by NG tube, not by long tube.
Recent studies have shown that long tube decompression is successful in 90% of patients with adhesive SBO. 29 For example, in every hospital in PA, USA, the standard use of improved long tube and gastrofiber scopes has increased the success rate of insertion to the small bowel to 90%, and most patients in whom decompression using short-tube insertion fails become candidates for long-tube insertion. 30 Thus, currently, long-tube insertion is strongly recommended because it provides significant clinical and economic advantages over short-tube insertion.
30
It is obvious that a short tube cannot sufficiently reduce intrasmall bowel pressure because the tube tip is located in the stomach.
F I G U R E 2 Forest plot of the occurrence of surgery for patients with postoperative small bowel obstruction and funnel plot analysis of such patients using integrated data However, it is clear that a long tube can more effectively reduce intra-small bowel pressure because the tube tip is located in the dilated small bowel and can effectively aspirate the accumulated intestinal fluid. Furthermore, the balloon of the long tube is able to assist insertion of the tube to the far distal side of the small bowel, beyond the obstructed portion.
In fact, even if PSBO patients with a short NG tube receive WSCM, effect of the WSCM is diluted by accumulated intestinal fluid in the dilated small bowel. However, if PSBO patients receive WSCM by a long tube, the WSCM can work more effectively in the decompressed small bowel or near the obstructed portion.
Although a prospective RCT comparing short-tube versus longtube insertion would be required to adequately assess the effect of Gastrografin in PSBO patients, the results of this meta-analysis clearly demonstrate that giving Gastrografin reduces the need for surgery in PSBO patients without long-tube insertion.
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